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Tobacco mosaic virus (TMV) is a devastating microorganism with a global distribution and a wide host 
range. Protein extracts isolated from Spinacia oleracea (spinach) were examined with bioassay-guide 
and tested for the resistance to TMV in the Nicotiana glutinosa leaves by local lesion assay. The results 
show that the crude extract and the fraction of 0 to 40% ammonium sulfate precipitation could protect 
tobacco from TMV infection. An active fraction was further purified with cation-exchange 
chromatography (SP-sepharose HP) and activity screening. The inhibitory rate for TMV in vitro was up 
to 94.35% with 50 µg/mL of the active fraction. In addition, this active fraction could function against 
TMV at the infection sites on leaves of N. glutinosa. However, it had only a little inhibitory effect on TMV 
replication and the mechanism under the TMV-inhibitory activity of protein extract from spinach still 
need further investigation.  
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INTRODUCTION 
 
Tobacco virus diseases are a class of widespread 
diseases on tobacco plants and destructive to tobacco 
yield and quality. Till now, 27 viruses have been isolated 
from tobacco, including Tobacco mosaic virus (TMV), 
Cucumber mosaic virus (CMV), Potato virus Y (PVY), 
Tobacco etch virus (TEV), Tobacco ring spot virus 
(TRSV), etc. Once infected by tobacco viruses, tobacco 
inherent chemical composition becomes unbalanced, leaf 
qualities deteriorate, yields and economic benefits 
decline dramatically (Lei, 2004). While inhibiting the 
viruses, anti-viral drugs may be harmful to the host 
plants, which are a major problem in controlling of plant 
virus diseases (Wu et al., 2008). 
TMV belongs to and is one of the representatives of 
the tobamovirus genus, which distribute widely all over 
the world and cause extensive damage for crop plants 
(Dawson et al., 1986). TMV  genome  is   composed  of  a  
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Abbreviation: TMV, Tobacco mosaic virus;  
single strand, positive strand RNA about 6.3 to 6.6 kb in 
length (Goelet et al., 1982). It could infect more than 300 
plant species, especially detrimental for tobacco plants. 
The most appropriate temperature for TMV proliferation is 
about 28 to 30°C. However, the virus is extremely stable 
in vitro. The virus could even live for more than 50 years 
in the dry tissues of plant (Zaitlin and Israel, 1975). 
Therefore, TMV prevention is a major problem for the 
tobacco production in the fields. The main measures in 
TMV defense include the using of TMV-resistant varieties, 
systematic cultivation techniques, chemically antiviral 
agents. Since the first plant virus resistant protein 
pokeweed antiviral proteins (PAP) was isolated from 
Phytolacca esculenta (Kassanis et al., 1948), scientists 
made great attempts at finding out the antiviral proteins 
from other plants. Nevertheless, a small number of plant 
anti-TMV protein extracts were obtained from Basella 
rubra, Bougainvillea spectabilis (Bolognesi et al., 2003), 
Boerhavia diffusa, (Verma et al., 1979), Bougainvillea 
xbuttiana (Narwal et al., 2001), Bryonia dioica (Stirpe et 
al., 1981), Cetosia cristata (Balasubrahmanyama et al., 
2000), Chenopodium amaranticolor (Taniguchi and Goto, 
1976), Clerodendrum aculeatum (Verma et al., 1996), 
Clerodendrum   inerme  (Olivieri  et  al.,  1996),   Cuscuta  
 
 
 
 
reflexa (Awasthi et al., 1981), Dinathus barbarus 
(Taniguchi and Goto, 1980), Dinathus caryophyllus 
(Stripe et al., 1981), Mirabilis jalapa (Kubo et al., 1990), 
Momordica charantia (Stevens et al., 1981), Nicotiana 
tabacum (Edelbaum et al., 1990), Phytolacca americana 
(Irvin et al., 1980; Bolognesis et al., 1990), Sambucus 
nigra (Chen et al., 2002), Silene schafta (Alexandre et al., 
1997), Yucca recurvifolia salisb (Naofumi and Akira, 
1987), etc.  
The annual or biennial spinach belongs to the Cheno-
podiaceae family and is widely cultivated in China. 
Currently, little has been reported about the application of 
spinach proteins in TMV control except that spinach 
crude extract could protect Nicotiana glutinosa plants 
from TMV (Cho et al., 2000). In this research, we further 
separated the anti-TMV proteins from the spinach crude 
extract. The mechanism under the anti-TMV ability of the 
active protein components was also primarily investigated.  
 
 
MATERIALS AND METHODS 
 
Materials 
 
N. glutinosa plants were used as local lesion host for bioassay and 
were grown in a growth chamber under 16 h light/8 h dark cycles at 
25°C, with 70% humidity. Uniform plants were selected for 
experiments. TMV was used to test the virus inhibitory activities of 
the spinach leaf extracts. The virus was maintained on its systemic 
host, K326. Spinach plants were purchased from local market. 
 
 
Purification of TMV 
 
TMV was purified according to Gooding (Gooding and Hebert, 
1967).  
 
 
Extraction and primary isolation of spinach protein 
 
Spinach leaves were homogenized with three volumes of 0.15 
mol/L phosphate buffer (pH7.2), containing 0.5 mmol/L 
phenylmethylsulfonyl fluoride (PMSF), 1 mmol/L 
ethylenediaminetetraacetic acid (EDTA) and 0.5 mmol/L 
dithiothreitol (DTT). The homogenate was squeezed through two 
layers of muslin cloth, and filtrate was centrifuged at 10000 g for 10 
min. The supernatant was used for primary purification. 
The supernatant obtained from leaf extract was subjected to 
ammonium sulfate fractionation at 40% saturation, by slow addition 
of solid ammonium sulfate with constant stirring at 4°C. The 
precipitated protein was centrifuged at 10000 g for 20 min. The 
precipitated protein pellet was suspended in minimal amount of 
0.01 mol/L phosphate buffer (pH 6.2) and dialyzed overnight 
against the same buffer at 4°C. 
For further purification, chromatography on SP Sepharose 
column was used. After equilibrating the SP Sepharose column with 
several volumes of 0.01 mol/L phosphate buffer (pH6.2), the active 
0 to 40% ammonium sulfate dialyzed protein fraction was loaded on 
the column and washed with equilibration buffer. The adsorbed 
protein was then eluted with a stepwise sodium chloride gradients 
(0.1, 0.25 and 0.5 mol/L), which was prepared in equilibration 
buffer. The eluted components were collected using a fraction 
collector system, at a flow rate of 1 mL/min. The eluted components 
were  simultaneously  monitored  for   absorbance  at  280 nm.  The  
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protein fractions were separately pooled and tested for the antiviral 
activity. 
Protein samples were analyzed using sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) with 12% 
acrylamide gel and visualized by staining with Coomassie Brilliant 
Blue R250 (Laemmli et al., 1970). 
 
 
Estimation of antiviral activity 
 
The antiviral activity of 0 to 40% ammonium sulfate fraction was 
estimated by local lesion assay. 0 to 40% ammonium sulfate 
fraction was mixed with equal volume of TMV (15 µg/mL) in 0.01 
mol/L phosphate buffer (pH 6.2) and the mixture was inoculated on 
carborundum-dusted N. glutinosa half-leaves. Half-leaves were 
rubbed with TMV solution that had been mixed with phosphate 
buffer as control. For each treatment, three plants with three to four 
leaves of equal size were used. Tobacco plants were observed for 
the development of lesions for three days. The antiviral activity of 
the proteins was calculated in terms of percentage inhibition using 
the following formula: inhibition = (C-T)/ C × 100%, C is the average 
number of lesions in control plants, and T is the average number of 
lesions in treated plants. 
 
 
The inhibitory effect of SPF5 peak-proteins against TMV in 
vitro 
 
N. glutinosa leaves were dusted with carborundum. 25, 12.5, 6.25 
and 3.125 µg/mL SPF5 fraction were mixed with equal volume of 15 
µg/mL TMV respectively and incubated for 30 min. The mixtures 
were mechanically inoculated onto one side leaves of N. glutinosa 
as the treatment, while another side of the leaves was inoculated 
with TMV solution diluted with the same volume of phosphate buffer 
buffer as the negative control.  
 
 
The inhibitory effect of SPF5 peak-proteins against TMV at the 
infection sites 
 
The half leaves of N. glutinosa were rubbed with 50 µg/mL SPF5 
fraction without carborumdum and another half leaves were rubbed 
with phosphate buffer as control. All test leaves were inoculated 
with TMV after 2, 5 and 9 h independently.  
 
 
The inhibitory activity against TMV replication of SPF5 peak-
proteins 
 
Growing leaves of N. glutinosa were inoculated both sides with 
equal volume of TMV. After 2, 5 and 9 h, the right side of the leaves 
were treated with the SPF5 fraction. The left half leaves were 
rubbed with phosphate buffer as control. 
 
 
RESULTS 
 
The antiviral activity of spinach crude extract and 0 
to 40% (NH4)2SO4 saturated fraction 
 
The antiviral activity of spinach crude extract was 
examined by local lesion. The results show that the 
inhibitory rate was 80.75% when 0.232 mg/mL crude 
extract was used, while the antiviral activity was up to 
92.36% when 0.325 mg/mL protein of 0 to 40% 
(NH4)2SO4  saturated  fraction was  used (Table 1). It  was  
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Table 1. Inhibition of TMV infection by the crude extract and 0 to 40% (NH4)2SO4 saturated fraction from spinach. 
 
Protein extract 
Sample concentration 
(µg/mL) 
Average lesion number
a
 
Inhibitory rate (%) 
Treated Control 
Crude extract 246 9.31 48.50 80.80 
0-40%(NH4)2SO4 saturated fraction 217 3.73 47.90 92.21 
 
a
Mean number of lesions on 9th to 10th leaves of nine tested plants from three independent experiments. TMV, Tobacco mosaic virus. 
 
 
 
 
 
Figure 1. Cation-exchange chromatography of 0 to 40% ammonium sulfate precipitation fractions from spinach on SP-
sepharose HP column. The displayed pictures are representative of three independent experiments. 
 
 
 
demonstrated that 0 to 40% (NH4)2SO4 saturated fraction 
contained a lot of antiviral proteins. 
 
 
Chromatography of 0 to 40% (NH4)2SO4 saturated fraction 
on SP Sepharose column 
 
The active fraction from ammonium sulfate fractionation 
was loaded onto a SP Sepharose column which had 
been equilibrated with 0.01 mol/L phosphate buffer (pH 
6.2). Equilibration buffer was used to wash the non-
specific binding proteins, and then a discontinuous 
gradient of NaCl (0.1, 0.25 and 0.5 mol/L) solutions were 
used to elute specific binding proteins. Five protein peaks 
appeared in the elution process (Figure 1). Peak was 
designated as SPF1 which was washed down by 
equilibration buffer. Such unabsorbed fraction indicated 
that the protein had the basic nature. Another two protein 
peaks were collected and named as SPF2 and SPF3 
respectively when the elution buffer containing 0.1 mol/L 
NaCl  was  used.  Accordingly,  SPF4  and  SPF5  were 
obtained separately corresponding to 0.25 mol/L and 0.5 
mol/L NaCl elution buffers.  
Furthermore, five protein peaks were pooled and 
dialyzed against ultra-pure water overnight at 4°C. The 
inhibitory activity of five collected peak-proteins was 
tested. The results suggested that the inhibitory rates of 
different peak-proteins (SPF1, SPF2, SPF3, SPF4) were 
17.78, 49.81, 43.53 and 32.58% respectively (Table 2). 
The SPF5 peak-proteins exhibited highly effective 
antiviral activity (91.43% local lesion inhibition) (Figure 
2a), which was consistent with the results got from 0 to 
40% (NH4)2SO4 saturated fraction, with relatively lower 
protein concentration compared to other four peak-
proteins. The protein components of SFP5 peak-proteins 
were separated by SDS-PAGE, and there were four main 
protein bands in the lane (Figure 2b). 
 
 
The inhibitory effect of SPF5 peak-proteins against 
TMV in vitro 
 
Different   concentrations  of   SPF5   peak-proteins  were 
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Table 2. The inhibitory effect against TMV of protein peaks from spinach purified with cation-exchange 
chromatography. 
 
Protein peak 
Sample concentration 
(µg/mL) 
Average lesion number
a
 
Inhibitory rate (%) 
Treated Control 
SPF1 566.00 33.71 41.00 17.78 
SPF2 462.67 22.83 45.50 49.81 
SPF3 289.16 24.00 42.50 43.53 
SPF4 64.81 29.67 44.00 32.58 
SPF5 31.03 3.67 42.78 91.43 
 
a
Mean number of lesions on 9th to 10th leaves of nine tested plants from three independent experiments. TMV, Tobacco 
mosaic virus. 
 
 
 
 
 
Figure 2. Biochemical properties of the SPF5 peak-proteins. (a) The inhibitory effect of SPF5 peak-proteins against TMV on 
the leaves of N. glutinosa. (b) SDS-PAGE analysis of antiviral proteins from spinach at different stages of purification. 1, 
Crude extract; 2, 0 to 40% (NH4)2SO4 saturated fraction; 3, SPF5 peak-proteins; M, molecular weight marker. The displayed 
pictures are representative of three independent experiments. TMV, Tobacco mosaic virus; SDS-PAGE, sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis. 
 
 
 
mixed with TMV and incubated for 30 min. The mixtures 
were mechanically inoculated onto adaxial half-leaves of 
N. glutinosa as treatment, while the other half part of the 
leaves were inoculated with TMV solution diluted with the 
same volume of phosphate buffer buffer as the negative 
control. The inhibitory rate was only 24.72% when 3.125 
µg/mL SPF5 peak-proteins were used, and the antiviral 
activity was up to 94.35% with 50 µg/mL SPF5 proteins. 
The results demonstrate that the inhibitory activities of 
SPF5 peak-proteins against TMV are positively relative to 
their concentrations (Table 3). The medium inhibitory 
concentration (IC50) of SPF5 fraction was 10 µg/mL. 
 
 
SPF5 peak-proteins function against TMV at the 
infection sites 
 
The half leaves of N. glutinosa were rubbed with 50 
µg/mL SPF5 peak-proteins without carborumdum and the 
other half leaves  were  rubbed with  phosphate  buffer as  
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Table 3. The inhibitory effect of SPF5 peak-proteins of different concentrations against TMV in vitro. 
 
Sample concentration 
(µg/mL) 
Average lesion number
a
 
Inhibitory rate (%) 
Treated Control 
50 2.67 47.17 94.35 
25 5.33 37.00 85.59 
12.5 15.00 44.25 66.10 
6.25 29.75 52.50 43.33 
3.125 33.50 44.50 24.72 
 
a
Mean number of lesions on 9th to 10th leaves of nine tested plants from three independent experiments. 
TMV, Tobacco mosaic virus. 
 
 
 
 
 
Figure 3. The inhibitory effect of SPF5 peak-proteins against 
TMV at the infection sites. TMV was inoculated on the right 
side of the leaves of N. glutinosa after pretreatment by SFP5 
peak-proteins for 9 h. The left side was control with 
pretreatment by PBS buffer. The displayed pictures are 
representative of three independent experiments. TMV, 
Tobacco mosaic virus; PBS, phosphate buffered saline. 
 
 
 
control. Leaves after pretreatment were inoculated with 
TMV at different time intervals. At 2, 5 and 9 h after the 
pretreatment, the inhibitory rates of TMV were 93.86, 
83.33 and 81.82%, which demonstrated that the SPF5 
peak-proteins could prevent TMV infection when it was 
sprayed on plant in advance (Figure 3 and Table 4).  
 
 
Inhibitory activity against TMV replication by SPF5 
peak-proteins 
 
Growing leaves of N. glutinosa were inoculated both 
leaves with equal volumes of TMV. The right adaxial 
sides of the leaves were  treated with  the  SPF5  peak-
proteins at different time intervals. Low inhibitory activity 
(46.86%) was detected when 50 µg/mL SPF5 peak-
proteins were used 2 h after TMV inoculation. Moreover, 
the inhibitory activities of SPF5 peak-proteins against 
TMV replication become fainter as the time interval 
increased (Table 5). After 9 h, the inhibitory rate was only 
26.89% (Figure 4). The results indicate that SPF5 peak-
proteins had little inhibitory activity against TMV 
replication.  
 
 
DISCUSSION 
 
Plants themselves produce a lot of actively physiological 
components, including organic chemicals and proteins. 
About one third pharmaceuticals and half of the total drug 
industry output contain extracts from plants. Exploitation 
of eco-friendly antiviral plant extract is a main focus when 
we seek ways to control plant virus diseases. Many of the 
antiviral components are plant proteins, such as PAP 
(Irvin et al., 1980; Chen et al., 1991) and mirabilis anti-
viral protein (MAP) (Kubo et al., 1990), both of which 
have high anti-virus activity. A basic protein isolated from 
the leaves of C. inerme could protect plants against CMV, 
PVY and TMV, and the inhibitory rate was more than 80% 
(Shelly et al., 2001). Ribosome inactivating protein (RIP) 
CIP-31 could destroy the coat protein synthesis process 
at sub-nanogram level without negative effect on the 
plant growth (Li et al., 2007).  
Crude extract of spinach has been found having high 
antiviral activity (Cho et al., 2000). We isolated a group of 
TMV inhibitive protein components using fraction 
precipitation by ammonium sulfate followed by cation-
exchange chromatography column chromatography. The 
active protein group with 94.35% inhibitory for TMV was 
eluted down at 0.5 M NaCl, which was designated as 
SPF5 peak-proteins. The components of SPF5 peak-
proteins were analyzed with SDS-PAGE and four bands 
were detected. Therefore, there was probably more than 
one component responsible for the anti-TMV activity of 
the protein group.  
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Table 4. Inhibitory rates of TMV at the infection sites by SPF5 peak-proteins. 
 
Time of pretreatment 
before TMV inoculation (h) 
Average lesion number
a
 
Inhibitory rate (%) 
Treated Control 
2  2.83 46.17 93.86 
5  7.00 42.00 83.33 
9  10.00 55.00 81.82 
 
a
Mean number of lesions on 9th to 10th leaves of nine tested plants from three independent experiments. TMV, Tobacco 
mosaic virus. 
 
 
 
Table 5. Inhibitory rates of TMV replication by the SPF5 peak-proteins. 
 
Time after TMV 
inoculation (h) 
Average lesion number
a
 Inhibitory rate 
(%) Treated Control 
2  23.25 43.75 46.86 
5  28.40 45.40 37.44 
9  31.00 42.40 26.89 
 
a
Mean number of lesions on 9th to 10th leaves of nine tested plants from three independent experiments. TMV, 
Tobacco mosaic virus. 
 
 
 
 
 
Figure 4. The inhibitory effect of SPF5 peak-proteins against TMV 
replication. TMV was inoculated on both sides of the leaves of N. 
glutinosa. After 9 h, SFP5 peak-proteins were used to treat the left 
side leaves and the right side leaves were treated with PBS buffer 
as controls. The displayed pictures are representative of three 
independent experiments. TMV, Tobacco mosaic virus; PBS, 
phosphate buffered saline. 
The antiviral components from plant could interact with 
virus directly (Chen et al., 2006), or they could occupy the 
virus infection sites (Baranwal et al., 1992). Otherwise, 
they might inhibit the replication of virus, either by 
interfering formation of the virus coat (Jiang et al., 1996; 
Shen et al., 2005) or by inhibiting the synthesis of virus 
protein and RNA (Hou et al., 2000). Our results indicate 
that SPF5 peak-proteins could inhibit the virus activity in 
a concentration-dependent way. TMV infection progress 
was slowed down when tobacco leaves was pretreated 
with SPF5 peak-proteins in advance. However, SPF5 did 
not have high inhibitory activity against TMV replication 
and proliferation when TMV had already infected tobacco 
plants. Therefore, SPF5 peak-proteins could not only 
destroy the interaction between TMV and its infection 
sites in vitro, but also might inhibit TMV replication in vivo. 
The former hypothesis should be the main reason for the 
anti-TMV ability of SPF5 peak-proteins.  
 
 
Conclusion 
 
In our study, SPF5 peak-proteins with TMV inhibitory 
activity was isolated from spinach. The in vitro tests 
showed that SPF5 peak-proteins had strong activities 
against TMV infection, but its inhibitory activity on TMV 
replication was not apparent. The functional protein in the 
SFP5 peak-proteins should be isolated further, and the 
molecular mechanisms under the phenomena would be 
the focus in the future research. Overall, identification of 
a small group of proteins with anti-TMV activity in this 
study provides more information for resistant proteins in 
plants and will advance our understanding of the 
application of resistant proteins for biological defense. 
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